For Patients

For-Patients-BellHow can we help? As you progress towards graduating from your personalized Hope cancer treatment program, remember, we are here for you, day and night. If you have questions, don’t hesitate to ask. Have concerns, requests or just want to talk? Our staff makes it their mission to provide you with the care you require, including a healthy dose of conversation.

Not only does Hope Cancer Care of Nevada provide our family of patients with leading cancer care, we also provide natural, holistic alternative treatments for an all-encompassing treatment program. From aromatherapy to Reiki massage specialists, these organic amenities are designed to support your primary medical treatment while providing an increased positive impact on your mind, body and spirit. These services are here at your discretion and may be recommended by your oncologist, for more information see The Hope Touch.

Treating the whole patient is the driving force behind Hope Cancer Care of Nevada, which includes generating a strong caregiver support system. Throughout your treatment, your caregiver may access our “For Caregivers” portal where they can obtain more information on how to best aid in your recovery. They will also have a direct link to your oncologist should questions arise. We understand that your caregiver plays a vital role in not only your healing, but your comfort as well.

If you are new to our family, take a moment to become more acquainted with Hope Cancer Care of Nevada by visiting our “Before You Arrive” page.

 

slide_0

NCI-COG Pediatric MATCH trial to test targeted drugs in childhood cancers

07/24/17

The nationwide precision medicine trial will enroll children and adolescents with advanced cancers that haven’t responded to standard therapy to explore treatments targeted at specific genetic mutations. …read more Source:: Cancer


TCGA study of liver cancer reveals potential targets for therapy

06/15/17

Only two drugs are FDA-approved for liver cancer. This study of hepatocellular carcinoma found genetic alterations in tumors—including mutations in tumor-suppressing genes and high expression of immune checkpoint genes—that could be targets for drugs that already exist. …read more Source:: … Read More


Don’t Fry Day: Getting Sunscreen Right

05/25/17

By David Sampson Despite increased awareness about the dangers of ultraviolet (UV) radiation, melanoma rates continue to rise in the United States. For “Don’t Fry Day” on May 26, the American Cancer Society is cautioning that many people may be … Read More


Ventilated Filters: Changing the Face of Lung Cancer in the U.S.

05/23/17

By David Sampson An analysis appearing in the Journal of the National Cancer Institute finds strong evidence that adding ventilation holes to cigarette filters has contributed to a rise in a type of lung cancer called adenocarcinoma among smokers. The … Read More


Study estimates number of U.S. women living with metastatic breast cancer

05/18/17

A new study shows that the number of women in the United States living with distant metastatic breast cancer (MBC), the most severe form of the disease, is growing. This is likely due to the aging of the U.S. population … Read More


14: The Unmentioned Number in the Prostate Cancer/Coffee Story

05/05/17

By David Sampson Headlines across the Internet blared with the news over the past week that coffee could cut the risk of prostate cancer in half. It was an irresistible headline. But just how reliable was the finding? What if … Read More


Panel Re-Opens the Door for PSA Screening in Men 55-69

04/11/17

By David Sampson The U.S. Preventive Services Task Force (USPSTF) has released draft recommendations for the use of prostate-specific antigen (PSA) screening for prostate cancer. The recommendation, which awaits public comment before being finalized, says the decision about whether to … Read More


Annual Report to the Nation: Cancer death rates continue to decline

03/31/17

According to the latest Annual Report to the Nation on the Status of Cancer, 1975-2014, overall cancer death rates continue to decrease in men, women, and children for all major racial and ethnic groups. But more work remains for some … Read More


The ‘Bad Luck’ Cancer Analysis, Part II

03/25/17

By David Sampson A new study revisits an analysis made by the same lab in 2015 about the role of random mutations on cancer. The analysis uses computer modeling to estimate how many cancers are the result of replication errors. … Read More


ACS Study: Finds Colorectal Cancer Rates Have Risen Dramatically in Gen X and Millennials

02/28/17

By David Sampson A groundbreaking study by American Cancer Society epidemiologist Rebecca Siegel, MPH finds that people born in the United States in 1990 have double the risk of colon cancer and quadruple the risk of rectal cancer compared to … Read More